Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica - Japan
doi 10.5631/jibirin.88.751
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Society of Practical Otolaryngology

Related search

Combined MTX-5FU-CBDCA for the Treatment of Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
2002English

Importance of AUC of Carboplatin in Head and Neck Cancer.

Journal of Otolaryngology of Japan
Otorhinolaryngology
1998English

Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A Comparative Evaluation of Accelerated Radiotherapy Versus Concomitant Chemoradiotherapy in Management of Locally Advanced Head and Neck Cancer

European Journal of Medicine
2016English

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy

Siriraj Medical Journal
Medicine
2020English

Sequential Chemoradiotherapy for Advanced Head and Neck Cancer: A Clinical Study With 33 Cases

Journal of Otolaryngology of Japan
Otorhinolaryngology
2016English

A Pilot Study of Carboplatin (JM8, CBDCA) and Chlorambucil in Combination for Advanced Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

Risk Factors for Aspiration Pneumonia During Concurrent Chemoradiotherapy or Bio-Radiotherapy for Head and Neck Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Dose-Volume Factors Correlating With Trismus Following Chemoradiation for Head and Neck Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy